Company / SG&A per Share
TREACE MEDICAL CONCEPTS, INC. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.77
FY2025
5-year range
$0.12 / $0.77
FY2021-FY2025
Trend
+29.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has increased for 3 consecutive years, from $0.12 in FY2022 to $0.77 in FY2025.
Based on SEC 10-K filings.
0.77 in FY2025 with a 3-year CAGR of +85.7%.
Increased from $0.33 to $0.77 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +85.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 29.5% year-over-year.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.77 | +29.5% |
| FY2024 | $0.60 | +80.2% |
| FY2023 | $0.33 | +174.5% |
| FY2022 | $0.12 | -0.2% |
| FY2021 | $0.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026